Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 29 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 11117900

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  2. US 11117888

    Irreversible inhibitors of pyruvate kinase M2 and the use thereof

    China Medical University · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  3. US 11117865

    Inhibitors of bromodomain-containing protein 4 (BRD4)

    The Board of Regents of the University of Texas System · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  4. US 11117867

    Crystalline salts of a plasma kallikrein inhibitor

    BioCryst Pharmaceuticals, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  5. US 11110082

    Tyrosine kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  6. US 11110103

    Inhibitors of glucocorticoid receptor

    ORIC PHARMACEUTICALS, INC. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  7. US 11110108

    Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  8. US 11110095

    Pyrimidine compounds as JAK kinase inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  9. US 11110086

    Compounds useful as inhibitors of ATR kinase and combination therapies thereof

    Vertex Pharmaceuticals Incorporated · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  10. US 11110090

    Aminopyrimidines as ALK inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  11. US 11110080

    Small molecule inhibitors of bacterial efflux pumps and methods of using same

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  12. US 11111270

    Inhibitor of apoptosis protein (IAP) antagonists

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  13. US 11104660

    PDE4D inhibitors

    Tetra Discovery Partners · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  14. US 11104730

    Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  15. US 11103504

    Combination of a DNA condensation-inducing compound and an Eis inhibitor for antibiotic treatment

    ACADEMISCH MEDISCH CENTRUM · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  16. US 11104689

    Influenza virus replication inhibitor and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  17. US 11104684

    Dimers of covalent NFKB inhibitors

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  18. US 11103491

    Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

    Asana BioSciences, LLC · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  19. US 11098042

    Inhibitors of influenza virus replication and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  20. US 11091509

    HPPK inhibitors useful as antibacterial agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  21. US 11091495

    Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors

    Mirati Therapeutics, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  22. US 11091472

    PI-kinase inhibitors with anti-infective activity

    The Regents of the University of California · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  23. US 11091501

    Heterocyclic compounds as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  24. US 11084809

    N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors

    KalVista Pharmaceuticals Limited · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted